Type II (adult Onset) Citrullinaemia: Clinical Pictures and the Therapeutic Effect of Liver Transplantation

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 2001 Oct 19

PMID 11606680

Citations 23

Authors

S Ikeda

M Yazaki

Y Takei

T Ikegami

Y Hashikura

S Kawasaki

M Iwai

K Kobayashi

T Saheki

Affiliations

Soon will be listed here.

Abstract

Objective: Adult onset type II citrullinemia is an inherited disorder of amino acid metabolism caused by a deficiency of liver specific argininosuccinate synthetase activity. Most of the patients with this disease were reported in Japan and therefore, this disease has not been well recognised outside this country. The detailed clinical pictures of the patients with type II citrullinaemia are reported and their outcomes after liver transplantation referred to.

Methods: Ten patients with this disease were evaluated. Seven of them underwent liver transplants using a graft obtained from a healthy family member.

Results: There were six men and four women; the age of onset of encephalopathy ranged from 17 to 51 years. The initial symptom in nine patients was sudden onset disturbance of consciousness, and one patient had long been regarded as having a chronic progressive psychotic illness. High concentrations of plasma citrulline and ammonia were commonly seen on admission. Although brain CT or MRI lacked any consistent findings, the EEG was abnormal in all patients, showing diffuse slow waves. Additionally, in five patients chronic pancreatitis preceded the onset of encephalopathy. After liver transplantation the metabolic abnormalities, including abnormal plasma concentrations of citrulline and ammonia, were immediately corrected and all neuropsychic symptoms soon disappeared, except for impaired cognitive function in one patient. Six out of these seven patients returned to their previous social lives, including work.

Conclusions: The clinical concept of adult onset type II citrullinaemia coincides well with the range of hepatic encephalopathy, and liver transplantation is a very promising therapeutic approach.

Citing Articles

The therapeutic landscape of citrin deficiency.

Vukovic T, Kuek L, Yu B, Makris G, Haberle J J Inherit Metab Dis. 2024; 47(6):1157-1174.

PMID: 39021261 PMC: 11586593. DOI: 10.1002/jimd.12768.

Citrin-deficient patient-derived induced pluripotent stem cells as a pathological liver model for congenital urea cycle disorders.

Okano M, Yasuda M, Shimomura Y, Matsuoka Y, Shirouzu Y, Fujioka T Mol Genet Metab Rep. 2024; 40:101096.

PMID: 38872960 PMC: 11170474. DOI: 10.1016/j.ymgmr.2024.101096.

Clinical landscape of citrin deficiency: A global perspective on a multifaceted condition.

Kido J, Makris G, Santra S, Haberle J J Inherit Metab Dis. 2024; 47(6):1144-1156.

PMID: 38503330 PMC: 11586594. DOI: 10.1002/jimd.12722.

Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment.

Suzuki T, Matsuura K, Imura N, Kawamura H, Kuno K, Fujiwara K Intern Med. 2023; 63(6):833-837.

PMID: 37495534 PMC: 11008984. DOI: 10.2169/internalmedicine.1954-23.

Challenges in pediatric inherited/metabolic liver disease: Focus on the disease spectrum, diagnosis and management of relatively common disorders.

Zou Y, Wang H, Li W, Dai D World J Gastroenterol. 2023; 29(14):2114-2126.

PMID: 37122598 PMC: 10130973. DOI: 10.3748/wjg.v29.i14.2114.

References

Saudubray J, Touati G, Delonlay P, Jouvet P, Narcy C, Laurent J . Liver transplantation in urea cycle disorders. Eur J Pediatr. 1999; 158 Suppl 2:S55-9. DOI: 10.1007/pl00014323. View

Oda M . [A CONTRIBUTION TO THE CLINICAL AND HISTOPATHOLOGICAL PROBLEM ON THE HEPATOCEREBRAL DISEASES WITH SPECIAL REFERENCE TO "PSEUDO-ULEGYRIA"]. Seishin Shinkeigaku Zasshi. 1964; 66:892-931. View

Ishikawa F, Nakamuta M, Kato M, Iwamoto H, Enjoji M, Miyata Y . Reversibility of serum NH3 level in a case of sudden onset and rapidly progressive case of type 2 citrullinemia. Intern Med. 2000; 39(11):925-9. DOI: 10.2169/internalmedicine.39.925. View

Yasuda T, Yamaguchi N, Kobayashi K, Nishi I, Horinouchi H, Jalil M . Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet. 2001; 107(6):537-45. DOI: 10.1007/s004390000430. View

Kasahara M, Ohwada S, Takeichi T, Kaneko H, Tomomasa T, Morikawa A . Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. Transplantation. 2001; 71(1):157-9. DOI: 10.1097/00007890-200101150-00027. View

Shiraki H, Oda M . [Pseudoulegyric type of hepatocerebral disease]. Naika. 1971; 28(3):491-8. View

Tsujii T, Morita T, Matsuyama Y, Matsui T, Tamura M, Matsuoka Y . Sibling cases of chronic recurrent hepatocerebral disease with hypercitrullinemia. Gastroenterol Jpn. 1976; 11(4):328-40. DOI: 10.1007/BF02777374. View

Saheki T, Ueda A, Hosoya M, Kusumi K, Takada S, Tsuda M . Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. Clin Chim Acta. 1981; 109(3):325-35. DOI: 10.1016/0009-8981(81)90318-1. View

Saheki T, Ueda A, Hosoya M, Sase M, Nakano K, Katsunuma T . Enzymatic analysis of citrullinemia (12 cases) in Japan. Adv Exp Med Biol. 1982; 153:63-76. DOI: 10.1007/978-1-4757-6903-6_9. View

10.

Saheki T, Kobayashi K, Inoue I . Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol. 1987; 108:21-68. DOI: 10.1007/BFb0034071. View

11.

Saheki T, Kobayashi K, Ichiki H, Matuo S, Tatsuno M, Imamura Y . Molecular basis of enzyme abnormalities in urea cycle disorders. With special reference to citrullinemia and argininosuccinic aciduria. Enzyme. 1987; 38(1-4):227-32. DOI: 10.1159/000469209. View

12.

Largilliere C, Houssin D, Gottrand F, Mathey C, Checoury A, Alagille D . Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr. 1989; 115(3):415-7. DOI: 10.1016/s0022-3476(89)80843-1. View

13.

Kobayashi K, Jackson M, Tick D, OBrien W, Beaudet A . Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J Biol Chem. 1990; 265(19):11361-7. View

14.

Todo S, Starzl T, Tzakis A, Benkov K, KALOUSEK F, Saheki T . Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology. 1992; 15(3):419-22. PMC: 2977958. DOI: 10.1002/hep.1840150311. View

15.

Makuuchi M, Kawasaki S, Noguchi T, Hashikura Y, Matsunami H, Hayashi K . Donor hepatectomy for living related partial liver transplantation. Surgery. 1993; 113(4):395-402. View

16.

Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, OBrien W, Beaudet A . A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet. 1993; 53(5):1024-30. PMC: 1682318. View

17.

Jan D, POGGI F, Jouvet P, Rabier D, Laurent J, Beringer A . Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. Transplant Proc. 1994; 26(1):188. View

18.

Mowat A . Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr. 1992; 151 Suppl 1:S32-8. DOI: 10.1007/BF02125800. View

19.

Kobayashi K, Shaheen N, Terazono H, Saheki T . Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am J Hum Genet. 1994; 55(6):1103-12. PMC: 1918437. View

20.

Kobayashi K, Nakata M, Terazono H, Shinsato T, Saheki T . Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEBS Lett. 1995; 372(1):69-73. DOI: 10.1016/0014-5793(95)00948-9. View